Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/23/2014US20140315853 Methods, formulations, and kits for rapidly repleting folate levels in women
10/23/2014US20140315852 Nucleoside phosphoramidate prodrugs
10/23/2014US20140315850 2',3'-Dideoxy-2'-alpha-Fluoro-2'-beta-C-Methylnucleosides and Prodrugs Thereof
10/23/2014US20140315849 Therapeutic agent for inflammatory diseases, containing adenosine n1-oxide as an effective ingredient
10/23/2014US20140315848 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140315845 Hsp90 inhibitors with modified toxicity
10/23/2014US20140315843 Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
10/23/2014US20140315842 Avermectins and Milbemycins as Anti-Mycobacterial Agents
10/23/2014US20140315841 Compositions comprising rifabutin, clarithromycin, and clofazimine and uses thereof
10/23/2014US20140315837 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
10/23/2014US20140315836 Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder
10/23/2014US20140315832 Pharmaceutical composition, methods for treating and uses thereof
10/23/2014US20140315821 Treatments involving eslicarbazepine acetate or eslicarbazepine
10/23/2014US20140315814 Synthetic pentasaccharides having short half-life and high activity
10/23/2014US20140315808 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology
10/23/2014US20140315807 Treatment and Prevention of Bone Loss Using Resolvins
10/23/2014US20140315805 Locally released growth factors to mediate motor recovery after stroke
10/23/2014US20140315803 Methods for stimulating hair growth
10/23/2014US20140315794 Antiparisitic dihydroazole compounds and compositions comprising same
10/23/2014US20140315786 Use of intracellular enzymes for the release of covalently linked bioactives
10/23/2014US20140315785 Methods related to the treatment of neurodegenerative and inflammatory conditions
10/23/2014US20140315781 Methods of treating fatty liver disease with helminth-derived glycan-containing compounds
10/23/2014US20140314888 Anti-inflammatory composition comprising malvidin -3 - o - beta-glucoside and a propolis extract
10/23/2014US20140314884 Health Supplement using Guarana Extract
10/23/2014US20140314882 Synergistic Combination Therapy
10/23/2014US20140314881 Novel medical uses for no and no donor compounds
10/23/2014US20140314879 Treatment of compartment syndrome
10/23/2014US20140314878 Compositions and methods for drug-sensitization or inhibition of a cancer cell
10/23/2014US20140314868 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
10/23/2014US20140314867 Vitamin k2 microspheres
10/23/2014US20140314866 Materials and methods for modulating immune responses
10/23/2014US20140314864 System for Targeted Delivery of Therapeutic Agents
10/23/2014US20140314863 Sustained release beads and suspensions including the same for sustained delivery of active ingredients
10/23/2014US20140314862 Sustained release beads and suspensions including the same for sustained delivery of active ingredients
10/23/2014US20140314861 Sustained release beads and suspensions including the same for sustained delivery of active ingredients
10/23/2014US20140314857 Formulations for enhanced bioavailability of zanamivir
10/23/2014US20140314856 Sustained release beads and suspensions including the same for sustained delivery of active ingredients
10/23/2014US20140314850 Functionalized nanodiamonds as delivery platforms for nucleic acids
10/23/2014US20140314848 Pharmaceutical compositions of antihypertensives
10/23/2014US20140314847 Controlled release pharmaceutical compositions with improved bioavailabililty
10/23/2014US20140314846 Multiple unit pharmaceutical formulation
10/23/2014US20140314845 Spherical erythritol granules for direct compression and process of producing same, process of producing tablets by tableting the erythritol granules with a pharmaceutically effective ingredient or nutritional ingredient, and tablets or ordinary candy tablets obtained thereby
10/23/2014US20140314844 Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability
10/23/2014US20140314842 Carbidopa/lipodopa gastroretentive drug delivery
10/23/2014US20140314841 Use of Cysteamine and Derivatives Thereof to Suppress Tumor Metastases
10/23/2014US20140314840 Ubiquinol and alpha lipoic acid compositions
10/23/2014US20140314835 Sustained release of antiinfectives
10/23/2014US20140314834 Gla monotherapy for use in cancer treatment
10/23/2014US20140314833 Methods and compositions involving mirna and mirna inhibitor molecules
10/23/2014US20140314827 Antimicrobial compositions and uses therefor
10/23/2014US20140314816 Stabilized stat3 decoy oligonucleotides and uses therefore
10/23/2014US20140314815 Adhesive solid gel-forming formulations for dermal drug delivery
10/23/2014US20140314794 Compositions and methods for the diagnosis and treatment of tumor
10/23/2014US20140314791 Methods of treating cancer
10/23/2014US20140314789 CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY
10/23/2014US20140314787 Treatment for neurodegenerative diseases
10/23/2014US20140314785 Compositions and methods for inhibition of the jak pathway
10/23/2014US20140314775 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment of anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
10/23/2014US20140314774 Her3 antibodies and uses thereof
10/23/2014US20140314771 Combination therapy of antibodies against human csf-1r and tlr9 agonist
10/23/2014US20140314758 Immunogenic tumor associated stromal cell antigen peptides and methods of their use
10/23/2014US20140314757 Phytocannabinoids for use in the treatment of breast cancer
10/23/2014US20140314753 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314752 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314751 Methods for treating cancer using tor kinase inhibitor combination therapy
10/23/2014US20140314746 Methods for treating or preventing fibrosis in subjects afflicted with scleroderma
10/23/2014US20140314742 Endoglin antibodies
10/23/2014US20140314740 Compositions and methods for the prevention or treatment of diabetic complications
10/23/2014US20140314731 Composition for protection against cell-damaging effects
10/23/2014US20140314730 Composition and methods for relief of chemical sensitivity
10/23/2014US20140314729 Nutraceutical formulation for treatment of elevated cholesterol and cardiovascular disease
10/23/2014US20140314714 Immunopotentiative composition
10/23/2014US20140314706 Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
10/23/2014US20140314704 Treatment of B Cell Lymphomas
10/23/2014US20140314695 Silicone scar treatment preparation
10/23/2014US20140314685 Ion channel modulating compounds and uses thereof
10/23/2014US20140314681 Poly-hapten with topical hormone alopecia hair regrowth system
10/23/2014US20140314680 Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
10/23/2014US20140314676 Methods of treatment with deferiprone
10/23/2014US20140314675 Cancer stem cell isolation
10/23/2014US20140314672 Nanoparticle therapeutic agents, their formulations, and methods of their use
10/23/2014US20140314664 Hydrophobic Molecule-Induced Branched Polymer Aggregates And Their Use
10/23/2014US20140311929 Liquid dosage form and delivery system
10/21/2014US8865911 Compounds and their use as BACE inhibitors
10/21/2014US8865910 1, 2, 4-triazole derivatives and their anti mycobacterial activity
10/21/2014US8865902 Deuterated CFTR potentiators
10/21/2014US8865901 Gain-of-function Bcl-2 inhibitors
10/21/2014US8865894 Oxazolidin-2-one compounds and uses thereof
10/21/2014US8865885 MicroRNA fingerprints during human megakaryocytopoiesis
10/21/2014US8865884 Antisense modulation of kinesin-like 1 expression
10/21/2014US8865878 Use of lipid conjugates in the treatment of diseases
10/21/2014US8865776 Use of low molecular weight amino alcohols in ophthalmic compositions
10/21/2014US8865775 Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same
10/21/2014US8865772 Method for treating skin cancer
10/21/2014US8865771 Amides useful as inhibitors of voltage-gated sodium channels
10/21/2014US8865770 Carbamide peroxide treatments for the reproductive tract
10/21/2014US8865769 Baclofen and acamprosate based therapy of neurological disorders
10/21/2014US8865768 Use of polyunsaturated ketones for the treatment of psoriasis
10/21/2014US8865767 Nutritional supplement composition promoting, increase, development, elevation and activation of “serotonin”
10/21/2014US8865765 Method for treating eczema
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 7860